Differential expression of function-related antigens on blood monocytes in children with hemolytic uremic syndrome.

GABRIELA C. FERNÁNDEZ; MARÝÍA V. RAMOS; SONIA A. GÓMEZ; GRACIELA I. DRAN; RAMÓN EXENI; MARTA ALDUNCÍN; IRENE GRIMOLDI; GRACIELA VALLEJO; CHRISTIAN ELÍAS-COSTA; MARTÍN A. ISTURIZ; MARINA S. PALERMO

JOURNAL OF LEUKOCYTE BIOLOGY

FEDERATION AMER SOC EXP BIOL

Año: 2005 vol. 78 p. 853 - 861

0741-5400

Monocytes (Mo) mediate central functions in inflammation and immunity. Different subpopulations of Mo with distinct phenotype and functional properties have been described. Here, we investigate the phenotype and function of peripheral Mo from children with hemolytic uremic syndrome (HUS). For this purpose, blood samples from patients in the acute period of HUS (HUS AP) were obtained on admission before dialysis and/or transfusion. The Mo phenotypic characterization was performed on whole blood by flow cytometry, and markers associated to biological functions were selected: CD14 accounting for lipopolysaccharide (LPS) responsiveness, CD11b for adhesion, Fc receptor for immunoglobulin G type I (Fc
RI)/CD64 for phagocytosis and cytotoxicity, and human leukocyte antigen (HLA)-DR for antigen presentation. Some of these functions were also determined. Moreover, the percentage of CD14 CD16 Mo was evaluated. We found that the entire HUS AP Mo population exhibited reduced CD14, CD64, and CD11b expression and decreased LPS-induced tumor necrosis factor production and Fc
-dependent cytotoxicity. HUS AP showed an increased percentage of CD14 CD16 Mo with higher CD16 and lower CD14 levels compared with the same subset from healthy children. Moreover, the CD14 CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed.
RI)/CD64 for phagocytosis and cytotoxicity, and human leukocyte antigen (HLA)-DR for antigen presentation. Some of these functions were also determined. Moreover, the percentage of CD14 CD16 Mo was evaluated. We found that the entire HUS AP Mo population exhibited reduced CD14, CD64, and CD11b expression and decreased LPS-induced tumor necrosis factor production and Fc
-dependent cytotoxicity. HUS AP showed an increased percentage of CD14 CD16 Mo with higher CD16 and lower CD14 levels compared with the same subset from healthy children. Moreover, the CD14 CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed. CD16 Mo was evaluated. We found that the entire HUS AP Mo population exhibited reduced CD14, CD64, and CD11b expression and decreased LPS-induced tumor necrosis factor production and Fc
-dependent cytotoxicity. HUS AP showed an increased percentage of CD14 CD16 Mo with higher CD16 and lower CD14 levels compared with the same subset from healthy children. Moreover, the CD14 CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed.
-dependent cytotoxicity. HUS AP showed an increased percentage of CD14 CD16 Mo with higher CD16 and lower CD14 levels compared with the same subset from healthy children. Moreover, the CD14 CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed. Mo with higher CD16 and lower CD14 levels compared with the same subset from healthy children. Moreover, the CD14 CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed. CD16– Mo subpopulation of HUS AP had a decreased HLA-DR expression, which correlated with severity. In conclusion, the Mo population from HUS AP patients presents phenotypic and functional alterations. The contribution to the pathogenesis and the possible scenarios that led to these changes are discussed.